Atara Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (ATRA)

CUSIP: 046513107

Q1 2022 13F Holders as of 31 Mar 2022

Holder snapshot 7 signals
Share change
+2,720,929
Put/Call ratio
0.83%
SEC-reported price per share
$9.29
Number of holders
139
Value change
+$12,542,757
Number of buys
72
Open additional details 1 more signal available
Number of sells
58
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
9,606,000

Security key

046513107

Report period

Q1 2022

Institutions

139

Top holders

10

Ownership snapshot

Top reported holders of ATRA - Atara Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BAUPOST GROUP LLC/MA
Disclosed value leader
BAUPOST GROUP LLC/MA
Comparable rows
15/15
Latest evidence
31 Dec 2021
13F Lead comparable stake: 88% Showing 1-6 of 15 holder rows.

Quick read

BAUPOST GROUP LLC/MA leads the comparable SEC ownership view at 88%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BAUPOST GROUP LLC/MA's linked filing trail.
Comparable ownership Top 5
BAUPOST GROUP LLC/MA 88%
MAVERICK CAPITAL LTD 82%
BlackRock Finance, Inc. 81%
JPMORGAN CHASE & CO 77%
VANGUARD GROUP INC 74%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BAUPOST GROUP LLC/MA
13F
Company
13F
88%
$133,605,000
8,477,488 shares
31 Dec 2021
MAVERICK CAPITAL LTD
13F
Company
13F
82%
$123,808,000
7,855,824 shares
31 Dec 2021
BlackRock Finance, Inc.
13F
Company
13F
81%
$123,190,000
7,816,552 shares
31 Dec 2021
JPMORGAN CHASE & CO
13F
Company
13F
77%
$116,894,000
7,417,122 shares
31 Dec 2021
VANGUARD GROUP INC
13F
Company
13F
74%
$111,510,000
7,075,521 shares
31 Dec 2021
Redmile Group, LLC
13F
Company
13F
67%
$101,459,000
6,437,777 shares
31 Dec 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
139
Shares
97,877,569
Rows available
139
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q4 2025 Across Filers

Q4 2025 holders
0
Q1 2022 holders
139
Holder diff
139
Investor Q4 2025 Shares Q1 2022 Shares Share Diff Share Chg % Q4 2025 value Q1 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .